Skip to content

Budesonide Impurity 2

Budesonide Impurity 2

Product Description
CAT No.
ALN-B022033
CAS No.
NA
Mol. F.
C21H24O4
Mol. Wt.
340.4
Stock
Please Inquire
Chemical Name : 2-((8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde with (8S,9S,10R,11S,13S,14S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
Smiles : O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@](O)([H])C[C@@]4(C)[C@@]3([H])CC=C4C(C([H])=O)=O)=C1.O=C5C=C[C@@]6(C)C(CC[C@]7([H])[C@]6([H])[C@](O)([H])C[C@@]8(C)[C@@]7([H])CC=C8C(C([H])(O)O)=O)=C5
Inchi : InChI=1S/C10H9ClN2/c1-7-8-4-2-3-5-9(8)13-10(6-11)12-7/h2-5H,6H2,1H3

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation